5,477
edits
No edit summary Tag: visualeditor-switched |
No edit summary |
||
| Line 626: | Line 626: | ||
==External links== | ==External links== | ||
* [https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management FDA - Zepbound for chronic weight management] | * [https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management FDA - Zepbound for chronic weight management] | ||
* [https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-reduce-risk-serious-heart-problems-specifically-adults-obesity-or FDA - Wegovy cardiovascular risk reduction] | * [https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-reduce-risk-serious-heart-problems-specifically-adults-obesity-or FDA - Wegovy cardiovascular risk reduction] | ||
| Line 654: | Line 653: | ||
[[Category:Metabolic health]] | [[Category:Metabolic health]] | ||
[[Category:Healthy lifestyle]] | [[Category:Healthy lifestyle]] | ||
__NOTOC__ | |||